Cannabis Legalization and Psychiatric Disorders: Caveat "Hemp-tor"

Overview

Journal Can J Psychiatry

Specialty Psychiatry

Date 2018 Feb 28

PMID 29482358

Citations 6

Authors

Tony P George

Kevin P Hill

Franco J Vaccarino

Affiliations

Soon will be listed here.

Citing Articles

Changes in Cannabis Use Patterns in Psychiatric Populations Pre- and Post-Legalization of Recreational Cannabis Use in Canada: A Repeated Cross-Sectional Survey.

Sorkhou M, Johnstone S, Weinberger A, Cooper Z, Sanches M, Castle D Cannabis. 2025; 7(3):1-13.

PMID: 39781550 PMC: 11705070. DOI: 10.26828/cannabis/2024/000238.

Cannabis Use Among Mental Health Professionals: A Qualitative Study of Cannabis-Related Risk Perceptions.

Ghelani A J Drug Issues. 2021; 51(4):679-689.

PMID: 34511638 PMC: 8427810. DOI: 10.1177/00220426211032558.

A Roadmap to Leadership During the Postgraduate Residency in India.

Suhas S, Vandita S, Vijaya R Indian J Psychol Med. 2021; 43(2):168-173.

PMID: 34376895 PMC: 8313446. DOI: 10.1177/0253717620957502.

How High? Trends in Cannabis Use Prior to First Admission to Inpatient Psychiatry in Ontario, Canada, between 2007 and 2017.

McGuckin T, Ferro M, Hammond D, Stewart S, Maloney-Hall B, Madi N Can J Psychiatry. 2020; 66(12):1059-1068.

PMID: 33380219 PMC: 8689428. DOI: 10.1177/0706743720984679.

Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Botsford S, Yang S, George T Am J Addict. 2019; 29(1):9-26.

PMID: 31577377 PMC: 6925309. DOI: 10.1111/ajad.12963.

References

Gage S, Hickman M, Zammit S . Association Between Cannabis and Psychosis: Epidemiologic Evidence. Biol Psychiatry. 2015; 79(7):549-56. DOI: 10.1016/j.biopsych.2015.08.001. View

Hill K . Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. JAMA. 2015; 313(24):2474-83. DOI: 10.1001/jama.2015.6199. View

Cerda M, Wall M, Feng T, Keyes K, Sarvet A, Schulenberg J . Association of State Recreational Marijuana Laws With Adolescent Marijuana Use. JAMA Pediatr. 2016; 171(2):142-149. PMC: 5365078. DOI: 10.1001/jamapediatrics.2016.3624. View

Vandrey R, Raber J, Raber M, Douglass B, Miller C, Bonn-Miller M . Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA. 2015; 313(24):2491-3. DOI: 10.1001/jama.2015.6613. View

Rabin R, George T . Understanding the Link Between Cannabinoids and Psychosis. Clin Pharmacol Ther. 2016; 101(2):197-199. DOI: 10.1002/cpt.421. View

Turna J, Patterson B, Van Ameringen M . Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depress Anxiety. 2017; 34(11):1006-1017. DOI: 10.1002/da.22664. View

Pausova Z, Paus T, Abrahamowicz M, Bernard M, Gaudet D, Leonard G . Cohort Profile: The Saguenay Youth Study (SYS). Int J Epidemiol. 2016; 46(2):e19. PMC: 5837575. DOI: 10.1093/ije/dyw023. View

Hill K, Weiss R . Minimal Physical Health Risk Associated With Long-term Cannabis Use--But Buyer Beware. JAMA. 2016; 315(21):2338-9. DOI: 10.1001/jama.2016.5181. View

Lynam D, Milich R, Zimmerman R, Novak S, Logan T, Martin C . Project DARE: no effects at 10-year follow-up. J Consult Clin Psychol. 1999; 67(4):590-3. DOI: 10.1037//0022-006x.67.4.590. View

10.

Grant K, Petroff R, Isoherranen N, Stella N, Burbacher T . Cannabis use during pregnancy: Pharmacokinetics and effects on child development. Pharmacol Ther. 2017; 182:133-151. PMC: 6211194. DOI: 10.1016/j.pharmthera.2017.08.014. View

11.

Hasin D, Saha T, Kerridge B, Goldstein R, Chou S, Zhang H . Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015; 72(12):1235-42. PMC: 5037576. DOI: 10.1001/jamapsychiatry.2015.1858. View

12.

Salomonsen-Sautel S, Min S, Sakai J, Thurstone C, Hopfer C . Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 2014; 140:137-44. PMC: 4068732. DOI: 10.1016/j.drugalcdep.2014.04.008. View

13.

Hasin D . US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology. 2017; 43(1):195-212. PMC: 5719106. DOI: 10.1038/npp.2017.198. View

14.

Hasin D, Sarvet A, Cerda M, Keyes K, Stohl M, Galea S . US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. JAMA Psychiatry. 2017; 74(6):579-588. PMC: 5539836. DOI: 10.1001/jamapsychiatry.2017.0724. View

15.

Wang G, Lait M, Deakyne S, Bronstein A, Bajaj L, Roosevelt G . Unintentional Pediatric Exposures to Marijuana in Colorado, 2009-2015. JAMA Pediatr. 2016; 170(9):e160971. DOI: 10.1001/jamapediatrics.2016.0971. View

16.

DeJong W, Blanchette J . Case closed: research evidence on the positive public health impact of the age 21 minimum legal drinking age in the United States. J Stud Alcohol Drugs Suppl. 2014; (17):108-15. DOI: 10.15288/jsads.2014.s17.108. View

17.

Hill K . Recreational cannabis legalisation: details will determine mental health effects. Lancet Psychiatry. 2016; 3(9):798-9. DOI: 10.1016/S2215-0366(16)30137-7. View

18.

Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson R . 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013; 368(4):341-50. DOI: 10.1056/NEJMsa1211128. View

19.

Hall W, Lynskey M . Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. Lancet Psychiatry. 2016; 3(9):900-6. DOI: 10.1016/S2215-0366(16)30071-2. View

20.

Rotermann M, Langlois K . Prevalence and correlates of marijuana use in Canada, 2012. Health Rep. 2015; 26(4):10-5. View